ACCESS TO DENTAL CARE FOR PRIORITY POPULATIONS
With
Professor Dileep Sharma,
Head of Discipline Oral Health,
School of Health Sciences,
University of Newcastle,
New South Wales, Australia
RESEARCHER PROFILE
Filmed in Ourimbah, New South Wales, Australia | November 2025
Professor Dileep Sharma is a distinguished dental educator and researcher who currently serves as Professor and Discipline Head of Oral Health at the University of Newcastle, Australia. With over two decades of experience spanning clinical practice, research leadership, and academic mentorship, Professor Sharma has established himself as a leading authority in oral health education and interdisciplinary research.
His academic journey includes a Master of Dental Surgery in Periodontics and a PhD from Griffith University, where his doctoral research focused on bisphosphonate-related osteonecrosis of the jaw. Professor Sharma’s leadership extends beyond research, having successfully led curriculum development and program accreditation processes, including the re-accreditation of the Bachelor of Oral Health Therapy program by the Australian Dental Council.
Professor Sharma has had significant career milestones, including receiving the James Cook University Dean’s Teaching Excellence Award in 2021 for innovative educational practices and research mentorship. He was internationally recognised as a Fellow of The International College of Dentists and The Pierre Fauchard Academy, and received the Joan Chong Award in Dental Materials in 2022. With over 80 peer-reviewed publications and nearly $1 million in competitive research funding, Professor Sharma has demonstrated research excellence. Additionally, he is currently supervising six PhD students, contributing to the successful completion of various research projects.
Professor Sharma’s current research focus is across 3 domains:
– Priority Population Research: Professor Sharma’s work addresses oral health disparities in underserved communities, including Aboriginal and Torres Strait Islander populations, refugee communities, and individuals with mental health conditions. His research encompasses oral cancer prevalence mapping in rural Australia and interventional strategies for vulnerable populations.
– Tissue Engineering & Bioactive materials: His expertise in regenerative medicine includes implant surface modifications, bioengineered materials, hydrogels, and 3D printing applications for periodontal regeneration. Notable work includes developing novel zirconia implant surfaces and VEGF-hydrogel delivery systems for prevention of medication-related osteonecrosis of the jaws.
– Public Health & Educational Research: Professor Sharma leads population health initiatives examining oral health-mental health connections, dental workforce development, and innovative educational methodologies. His scholarship of teaching and learning research focuses on enhancing clinical education and professional competency development in dental and oral health programs.
Source: Supplied and adapted
https://orcid.org/0000-0003-4463-1480
-
Next Generation Condom Contraception, Dr Simon Cook
Dr. Simon Cook, Co-Founder and Executive Director of Operations at Eudaemon Technologies, has had a diverse and impactful career journey. Beginning with a background in biotechnology from the University of Wollongong, his focus on bacterial pathogenesis during his PhD led him to study Group A Strep and the streptokinase protein.
Subsequently, Dr. Cook ventured into a unique project funded by the Bill and Melinda Gates Foundation, where he became involved in the development of a next-generation condom to address existing issues such as feel, odour, and taste.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
-
Stem cell therapies for enteric neuropathies
Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.
